HNRNPU and Global developmental delay: An other splicing factor, HNRNPU, which we identified to co-purify with CSB-TAP, when mutated gives rise to clinical features that are shared by CS patients: microcephaly, developmental delay, hearing loss, vertebral anomalies and characteristic facial features [37, 38].